Karolinska ATMP Center in focus
At Karolinska’s ATMP Center, innovative treatments for incurable diseases are being developed by modifying gene and tissue cells. Hear from the new Director, Knut Steffensen, and Coordinator, Ewa Ellis, as they explain why ATMP is vital for healthcare and the future.
By modifying gene and tissue cells, new possibilities are emerging to treat diseases that currently lack a cure. We spoke with the new ATMP Director, Knut Steffensen, and coordinator, Ewa Ellis, who share why this groundbreaking field is essential for the future of medicine—and what we can expect moving forward.
Watch the video here!
Click on the image below to see the video. It will open in a new window.
Film: Fredric Möller Eklund.
Similar news
Researchers at Karolinska Institutet and the Astrid Lindgren Children’s Hospital in Sweden have determined how children’s immune systems react to different kinds of cancer depending on their age. The study, which is published in the journal Cell, reveals s...
The EUHA Members' Assembly, held at Karolinska University Hospital from June 12-14, convened international healthcare leaders to discuss innovative solutions for future challenges. Highlights included the EUHA Symposium on AI and high-quality care, and a r...